No return to old normal in foreseeable future: WHO chief

Agencies
July 14, 2020

UN, Jul 14: There will be no return to the "old normal" for the foreseeable future as a result of the ongoing COVID-19 pandemic, and too many countries were still headed in the wrong direction, the chief of the World Health Organization (WHO) warned.

"The virus remains public enemy number one, but the actions of many governments and people do not reflect this," Xinhua news agency quoted WHO Director-General Tedros Adhanom Ghebreyesus at as saying a regular briefing on Monday.

He noted that mixed messages from leaders are undermining trust, which is the most critical ingredient of any response, while the only aim of the virus is to find people to infect.

Things are going to "get worse and worse and worse", he warned, unless governments communicate clearly with their citizens and roll out a comprehensive strategy focused on suppressing transmission and saving lives, while populations follow the basic public health principles of physical distancing, hand washing, wearing masks, coughing etiquette and staying home when sick.

COVID-19 has been gaining its momentum lately.

According to Tedros, Sunday saw a record of 230,000 cases reported to WHO, of which almost 80% were from just 10 countries and about half from just two countries.

"But it does not have to be this way," he said, asking every single leader, government and individual "to do their bit to break the chains of COVID-19 transmission and end the collective suffering".

To control the disease and get on with people's lives, Tedros said, three things are required. The first is to focus on reducing mortality and suppressing transmission; the second is to focus on an empowered, engaged community that takes individual behaviour measures in the interest of each other.

And the third is a strong government leadership and coordination of comprehensive strategies that are communicated clearly and consistently.

"We weren't prepared collectively, but we must use all the tools we have to bring this pandemic under control. And we need to do it right now," he added.

At the WHO briefing on Monday, health experts also said there was evidence to suggest that children under the age of 10 were only very mildly affected by Covid-19, while those over 10 seemed to suffer similar mild symptoms to young adults.

To what extent children can transmit the virus, while it appears to be low, remains unknown.

On Tuesday, the number of global coronavirus cases cross the 13 million mark, according to the Johns Hopkins University.

The total number of cases currently stood at 13,070,097, while the fatalities rose to 572,411, the University's Center for Systems Science and Engineering (CSSE) revealed in its latest update.

The US accounted for the world's highest number of infections and fatalities at 3,363,056 and 135,605, respectively, according to the CSSE.

Brazil came in the second place with 1,884,967 infections and 72,833 deaths.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
September 26,2020

WHO.jpg

The World Health Organisation (WHO) warned that the global coronavirus death toll could hit two million before an effective vaccine is widely used.

WHO emergencies head Mike Ryan on Friday said the figure could be even higher without concerted international action, the BBC reported.

The number of Covid-19 deaths is fast approaching one million - nine months after the outbreak started in China.

Ryan also urged Europeans to ask themselves whether they had done enough to avoid the need for lockdowns.

He questioned whether all the alternatives had been implemented, like testing and tracing, quarantine, isolation, social distancing, wearing masks and hand-washing.

Earlier, Spain's capital Madrid brought another eight districts under tougher coronavirus restrictions, which now affect a million people in the city.

In France, staff from bars and restaurants in the southern city Marseille protested against the closure of their workplaces which was brought in on Saturday.

And in the UK, tougher restrictions were announced in several regions as new daily infections rise.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
September 17,2020

covid.jpg

New Delhi, Sept 17: Union Health Minister Harsh Vardhan on Thursday said that the coronavirus vaccine will be made available in the country by the start of next year. The remarks come at a time when India is recording more than 50 lakh cases and people are awaiting the vaccine with bated breath.

"Just like other countries, India is also making efforts. Three vaccines candidates are in different phases. Under Prime Minister's guidance, an expert group is looking at it and there is advanced planning in place. We are hopeful that by the start of next year a vaccine will be available in India," Harsh Vardhan said in Rajya Sabha.

Two indigenous vaccines by Zydus Cadila and Bharat Biotech have completed phase 1. Serum Institute of India (SII) has again commenced the trials after getting clearance from the Drug Controller General of India.

India is the manufacturing partner of the vaccine candidate named Covishield, developed jointly by the University of Oxford's Jenner Institute's and AstraZeneca. The Pune-based firm, SII, is looking after the trials at 17 trial sites across India.

Besides this, the Russian Direct Investment Fund (RDIF) and Dr. Reddy's Laboratories Limited, a global pharmaceutical company headquartered out of India, have agreed to cooperate on clinical trials and distribution of Sputnik V vaccine in India.

Sputnik V, an adenovirus vector-based vaccine, was developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology, along with the Russian Direct Investment Fund and registered on August 11.

"On regulatory approval in India, RDIF shall supply to Dr. Reddy's 100 million doses of the vaccine. The Sputnik V vaccine, which is based on well-studied human adenoviral vector platform with proven safety, is undergoing clinical trials for the coronavirus pandemic," said a statement from the fund.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
September 18,2020

cancer.JPG

Ludhiana, Sept 18: DMCH Cancer Care Centre in collaboration with American Oncology Institute recently started a new diagnostic service (PSMA-PET Scan) in treating various prostate cancer.

Prostate cancer is the most common cancer in men and one of the leading causes of cancer death. Prostate Specific Membrane Antigen (PSMA ) is highly expressed in prostate cancer and its expression increases with tumour aggressiveness, metastatic disease and disease recurrence.

Secretary of DMCH Managing Society, Sh. Prem Kumar Gupta said, “Very few facilities in the region have this state-of-art facility and will be of great benefit for the patients.” He further added, “DMCH Cancer Care Centre is always in the process of acquiring new techniques and facilities for diagnosing and treating various cancer diseases. The availability of this facility will go a long way to help both patients and clinicians in knowing about the proper stage of prostate cancer, thereby helping patients with better outcome.”

Dr. Puneet Bhutani from the Department of Nuclear Medicine, American Oncology Institute stated, “This is a major milestone in diagnosis of prostate cancer. The procedure of diagnosing prostate cancer through PSMA-PET Scan is more accurate method for early detection of recurrent disease. It allows the oncologists to treat patients at an early stage and provide them a better treatment outcome.”

About American Oncology Institute:

American Oncology Institute is the leading cancer care provider across South Asia operating a chain of cancer hospitals in multiple cities across South Asia. AOI today is a wholly owned subsidiary of Varian Medical Systems (NYSE: VAR).

The team of clinical, paraclinical and healthcare operations experts pride themselves with the aim of closing the gap between standards of cancer care in South Asia and the developed cancer hospitals in the West. AOI provides comprehensive cancer management that is powered by clinical excellence, world class technology as well as best in class clinical pathways and protocols for treatment planning and execution, providing best in-class quality in cancer care across South Asia.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.